LifeMD, Inc.

53
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US53216B1044
USD
3.73
0.17 (4.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
LifeMD, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-18.00
-17.00
-44.00
-61.00
-60.00
-3.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
12.00
4.00
-1.00
9.00
8.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
17.00
8.00
-22.00
-33.00
-12.00
0.00
Cash Flow from Investing Activities
-11.00
-8.00
-13.00
-3.00
0.00
0.00
Cash Flow from Financing Activities
-4.00
29.00
0.00
68.00
21.00
0.00
Net Cash Inflow / Outflow
1.00
29.00
-37.00
32.00
8.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of LifeMD, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-18.326498
-684.211
666.00
97.32%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
12.648201
43.355
-31.00
-70.83%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
17.51319
-46.913
63.00
137.33%
Cash Flow from Investing Activities
-11.536318
-14.611
3.00
21.04%
Cash Flow from Financing Activities
-4.118673
85.427
-89.00
-104.82%
Net Cash Inflow / Outflow
1.858199
23.903
-22.00
-92.23%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 98.56% vs 138.46% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
17.51
8.82
98.56%